Oldest pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #101 to #150.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Benralizumab (Fasenra) (16:42, 27 May 2021)
- P-glycoprotein modifying drugs (21:42, 26 August 2021)
- Caspofungin (Cancidas) (04:14, 20 September 2021)
- Long-Term Data Reinforce Standard of Care in Unresectable Melanoma (19:45, 5 December 2021)
- Aspirin and dipyridamole (Aggrenox) (22:08, 22 March 2022)
- Amoxicillin (19:03, 25 April 2022)
- Omeprazole (Prilosec) (19:03, 25 April 2022)
- Clarithromycin (Biaxin) (19:05, 25 April 2022)
- Lansoprazole (Prevacid) (19:05, 25 April 2022)
- Bismuth subsalicylate (Pepto-Bismol) (19:06, 25 April 2022)
- Ampicillin (19:07, 25 April 2022)
- Metronidazole (Flagyl) (19:08, 25 April 2022)
- Tripotassium dicitratobismuthate (De-Noltab) (19:08, 25 April 2022)
- Tetracycline (Sumycin) (19:09, 25 April 2022)
- Doxycycline (19:10, 25 April 2022)
- Colchicine (Colcrys) (13:42, 26 April 2022)
- Cortisone (13:43, 26 April 2022)
- Cyproterone acetate (Androcur) (13:45, 26 April 2022)
- Diethylstilbestrol (DES) (02:11, 27 April 2022)
- Doxifluridine (Didox) (12:07, 27 April 2022)
- Estradiol (17:55, 27 April 2022)
- Urethane (02:01, 29 April 2022)
- Valproate (Depakote) (02:02, 29 April 2022)
- Plinabulin (NPI-2358) (02:18, 29 April 2022)
- Iodine-131 (22:39, 1 May 2022)
- Dexchlorpheniramine (Polaramine) (16:33, 17 May 2022)
- Carboplatin, Pemetrexed, Pembrolizumab in advanced or metastatic non-small cell lung cancer (11:19, 26 July 2022)
- Biomarkers (18:32, 5 August 2022)
- Aumolertinib (Amelie) (10:59, 20 September 2022)
- Radotinib (Supect) (23:44, 26 September 2022)
- Atropine (Atropen) (00:38, 27 September 2022)
- Endocrine ablation surgery (12:34, 28 September 2022)
- Aminopterin (12:30, 4 December 2022)
- Folic acid (Folate) (12:34, 4 December 2022)
- University of California (San Francisco) Hematology Oncology Fellowship (19:22, 9 February 2023)
- HLH-2004 for untreated hemophagocytic lymphohistiocytosis (HLH) (02:45, 28 February 2023)
- Olutasidenib (Rezlidhia) (15:54, 21 April 2023)
- Clobetasol (00:46, 26 April 2023)
- Sodium bicarbonate (00:49, 26 April 2023)
- Normal saline (00:50, 26 April 2023)
- Carbasalate calcium (Ascal) (00:54, 26 April 2023)
- Erythromycin (00:58, 26 April 2023)
- Testosterone cypionate (00:59, 26 April 2023)
- Amatuximab (MORAb-009) (13:22, 26 April 2023)
- Vesicant & irritant chemotherapy (14:24, 26 April 2023)
- Vorolanib (CM-082) (14:42, 26 April 2023)
- Factor IX, recombinant, Fc fusion protein (Alprolix) (15:03, 26 April 2023)
- Crenolanib (CP-868,596) (23:13, 26 April 2023)
- Pathology (23:16, 26 April 2023)
- Steroid conversions (23:27, 26 April 2023)